Article
High-Throughput Targeted Drug Screening for NF1-associated High-Grade Gliomas with ATRX Deficiency
2024-12-17
Abstract excerpt
Neurofibromatosis type 1 (NF1)-associated high-grade gliomas (HGGs) harboring ATRX mutations exhibit an aggressive clinical phenotype, driven by heightened genomic instability and metabolic reprogramming. Existing therapies, including chemotherapy and radiotherapy, are limited by resistance mechanisms and formation of secondary malignancy, underscoring the need for novel therapeutic strategies. Here, we report the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0b8078d0-5d58-5bd0-bb1f-9f98abc437e0
- DOI
- 10.1101/2024.12.14.628525
